Publizoom

Award notice Supplies

4 Prorroga-Suministro de VUTRISIRAN (AMVUTTRA 25 mg solución inyectable jeringa) de distribución exclusiva, con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
HOSPITAL CLINICO SAN CARLOS DE MADRID
MADRID
Place of performance
Madrid
Estimated value
€14,977,367 excl. VAT
Amount awarded
€1,357,948 excl. VAT
Planned end of contract
19 January 2027
likely re-tender around October 2026
Bids received
1
Procedure
Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication
21 July 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

4 Prorroga-Suministro de VUTRISIRAN (AMVUTTRA 25 mg solución inyectable jeringa) de distribución exclusiva, con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below
€350,000
Median
€846,164
A quarter above
€2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Suministro de Eplontersen (WAINZUA) de distribución exclusiva . con destino al Servicio de Farmacia del Hospital Clínico San Carlos
HOSPITAL CLINICO SAN CARLOS DE MADRID · 22 October 2026
ASTRAZENECA FARMACÉUTICA SPAIN, S.A. €160,015
7ª Prórroga + MODIFICACION Suministro de RAVULIZUMAB (ULTOMIRIS) solución inyectable, de distribución exclusiva para el Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
HOSPITAL CLINICO SAN CARLOS DE MADRID · 5 October 2026
Alexion Pharma Spain, S.L.U €2,022,701
Prorroga adelantada suministro del medicamento piflufolastat (18f) (pylclari®) de distribución exclusiva, con destino al servicio de farmacia del hospital clínico san carlos de madrid
HOSPITAL CLINICO SAN CARLOS DE MADRID · 7 September 2026
CURIUM PHARMA SPAIN, S.A. €420,014
Suministro de Tafasitamab (DOE)
OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026
INCYTE BIOSCIENCES IBERIA, S.L. €2,170,000
Suministro de IODIXANOL (VISIPAQUE) E IOHEXOL (OMNIPAQUE) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos
HOSPITAL CLINICO SAN CARLOS · 23 October 2026
GE HEALTHCARE BIO-SCIENCES, SAU €505,350

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 501647-2026.